While evidence shows breastmilk-fed infants are less prone to NCDs than formula-fed infants, further information is needed to understand ‘why’.
Breastmilk lipids and lipid metabolites are emerging as key potential protectors against obesity, type 2 diabetes, inflammation and metabolic dysfunction, and resulting NCDs – diseases predicted to contribute to 75% of deaths worldwide by 2030.
Researchers lay out what we know, what we still need to learn, and suggest ways forward in the Special Issue Maternal and Infant Health: The Molecular Nutrition Perspective published by the International Journal of Molecular Sciences.
Find all the details here: The Role of Human Milk Lipids and Lipid Metabolites in Protecting the Infant against Non-Communicable Disease.
FLRF is proud to have helped sponsor this work via a Trainee Bridge Fund research grant from the ISRHML – Family Larsson-Rosenquist Foundation Trainee Expansion Program (TEP) to lead author, Dr. Alexandra D. George, supporting her research to understand these milk lipids and lipid metabolites and their importance in early life. Stay tuned for more news to come!
TEP grant applications are now open for early career researchers and students in human milk and lactation. Are you interested? Applications close 1 October 2022 – apply here.